Manuel Schabus
|17.06.2025
The emergence of validated HRV-based sleep staging opens new possibilities for population-level sleep science. This article explores several use cases for large-scale studies using wearable, non-invasive sleep monitoring. We highlight opportunities for epidemiology, mental health research, chronobiology, clinical trials, and public health surveillance. These examples demonstrate how scalable methods can complement traditional polysomnography and expand the reach and scope of sleep-related investigations.
Polysomnography has long provided the gold standard for sleep staging but remains unsuitable for high-volume or long-duration field studies. Recent advances in machine learning and wearable biosensors allow for alternative approaches that are cost-efficient, participant-friendly, and ecologically valid. This creates new opportunities for research at scale—across thousands of participants, multiple nights, and diverse settings.
In what follows, I present five applied use cases for large-scale sleep research that can be realized through validated HRV-based sleep monitoring systems.
Shift work has been associated with disrupted circadian rhythms, impaired cognitive performance, and long-term health consequences including metabolic and cardiovascular risks. Yet most studies rely on actigraphy or sparse self-reports. There is limited objective data on how sleep architecture adapts over time under chronodisruptive conditions.
Sample size: 500+ participants across multiple industries (e.g., healthcare, logistics)
Sample subgroups: Compare samples by sex and age and see where the impact is most pronounced
Duration: 12-24 weeks, capturing night shifts, recovery days, and off-cycles
Outcomes: Full set of sleep variables including Sleep onset latency (SOL), REM proportion, sleep efficiency as well as heart rate and HRV measures at night
By collecting HRV-based sleep stage data over time, researchers can model recovery dynamics, inter-individual variability in sleep resilience, and long-term adaptation patterns. Coupling with cognitive assessments or performance metrics can yield a holistic view of sleep–work–function interactions. HR and HRV at night provide sensitive indicators of systemic recovery, offering insight into whether the brain and body enter restorative states or remain under sustained physiological strain.
There is growing recognition of sleep as a public health concern. However, most epidemiological data stem from subjective measures (e.g., PSQI) or limited cross-sectional snapshots. Objective sleep metrics in representative samples are largely missing.
Sample size: 5,000–50,000 individuals (via health insurers, apps, or public health registries)
Duration: 7–14 nights per participant
Stratification: Age, gender, socioeconomic status (SES), geographic regions, chronotype
With high-throughput HRV-based monitoring, it becomes possible to construct regional or demographic sleep profiles, track secular trends, and detect population-level risk patterns (e.g., increasing WASO with age, reduced REM in low-SES groups). This can inform prevention strategies, urban planning (noise/light), and health policy. In addition such data not only uncovers subjective burden but also comes with objective measures related to life-quality or even life expectancy.
Sleep disturbances often precede clinical onset of neuropsychiatric conditions such as depression, anxiety, or neurodegeneration. Detecting subtle changes in sleep patterns may thus provide early-warning indicators of mental or neurological decline.
Sample size: 1,000+ participants at elevated risk (e.g., family history, early symptoms)
Duration: 3–6 months of continuous monitoring
Data fusion: Sleep staging + passive smartphone sensing + EMA
Monitoring objective sleep trajectories alongside digital behavioral markers (e.g., phone use, mobility) can allow for predictive modeling of mental health transitions. Early deviations isuch as in REM continuity or sleep fragmentation may serve as biomarkers in preclinical stages.
CBT-I is the first-line treatment for insomnia, yet access and adherence remain challenges. Digital programs offer scalability, but real-world efficacy must be rigorously evaluated—ideally with both subjective and objective outcomes.
Sample size: 800–1,200 adults with self-reported insomnia
Design: Randomized controlled trial (intervention vs. waitlist or placebo)
Outcomes: Changes in measures such as SOL, WASO, TST over 6–8 weeks
Pairing digital CBT-I with HRV-based sleep staging allows researchers to move beyond self-report and quantify physiological improvements. Moreover, subgroup analyses (e.g., responders vs. non-responders) may uncover moderators such as baseline REM duration or sleep efficiency.
Most normative data on sleep architecture stem from laboratory studies with small, healthy cohorts and often fixed time in bed (TIB) windows. Moreover in Western countries, studies suggest that about 60–70% of adults regularly sleep with a bed partner (spouse or romantic partner) in the same bed or room; all existing normative data are nights without a bed partner. Little is also known about real-world sleep patterns in children, adolescents, or older adults across multiple nights and seasons.
Sample size: 5,000+ participants aged 6–85 years, with or without bed partner
Duration: 10 nights (multiple seasons or school/work periods)
Analysis: Age-related changes in sleep stage proportions, sleep onset latency, efficiency or frequency of awakenings
Such a dataset could define real-world sleep norms by age group, inform pediatric sleep guidelines, and assess developmental or aging-related shifts in sleep architecture. Temporal granularity enables analysis of weekday–weekend differences, seasonal variation, or circadian drift. Moreover such a dataset could finally reveal how people sleep in the real-world (with their usual sleep routines at home, and with/without bed partners).
When scaling sleep research, several challenges must be addressed:
Data Quality Control: Ensuring IBI data are free from movement artifacts or signal loss (and/or are corrected or at least flagged as unreliable epochs)
Participant Training: Clear protocols for sensor use and troubleshooting
Ethics & Privacy: Transparent consent, pseudonymization, and data handling policies
Algorithm Bias: Validating models across age, gender, medication and health status
While wearable-based approaches help democratize access to sleep measurement, they require rigorous validation, transparent documentation, and clear reporting standards—especially given the reduced experimental control compared to laboratory settings.
Scalable HRV-based sleep staging systems open the door to ambitious new research designs—both observational and interventional. As sleep increasingly intersects with public health, mental well-being, and cognitive functioning, there is a pressing need for tools that can assess sleep in large, diverse populations over time.
From shift workers to schoolchildren, from high-performance athletes to patients in digital trials, sleep science is poised to go wide, not just deep. The challenge—and the opportunity—is to design studies that meet this moment.
Topalidis, P., Heib, D. P., Baron, S., Eigl, E. S., Hinterberger, A., & Schabus, M. (2023). The virtual sleep lab—a novel method for accurate four-class sleep staging using heart-rate variability from low-cost wearables. Sensors, 23(5), 2390. https://doi.org/10.3390/s23052390
Hachenberger, J., Baron, S., Schabus, M., & Lemola, S. (2025). The role of objective sleep duration, continuity, and architecture for subjective sleep perception. Sleep Medicine, 129, 167–174. https://doi.org/10.1016/j.sleep.2025.02.040
Kurapov, A., Blechert, J., Hinterberger, A., Topalidis, P., & Schabus, M. (2024). Non-guided, Mobile, CBT-I-based Sleep Training in War-torn Ukraine: A Feasibility Study. bioRxiv. https://doi.org/10.1101/2024.0...
Vertraue nicht weiter auf kurzfristige Lösungen, sondern wähle nachhaltige Verbesserungen mit sleep². Beginne jetzt dein Intensivprogramm und setze den wegweisenden Schritt zu einem gesunden, natürlichen Schlaf.